Beverley Carr

Beverley has over 20 years’ experience in business development in biotech and pharmaceutical companies. She was previously Chief Business Officer at Achilles Therapeutics plc, and prior to this was Vice President Business Development for the Immunoinflammation Therapy Area at GSK. Beverley has negotiated and closed over thirty-five major deals across all stages of drug discovery and development.

Beverley is a scientist by training with an MA and DPhil in chemistry from Oxford University and has an MBA from Cambridge University.